The FDA said the silicon foam used in some reworked ventilator models may separate from plastic backing due to adhesive failure and can reduce the air flow as well as cause debris contamination. The issue can lead to patient injury or death.
Featured Posts
Lawyers for a man who alleges he developed bladder cancer after taking GSK Plc’s heartburn drug Zantac urged a California judge on Thursday to allow expert testimony linking the drug to the illness at an upcoming trial.
Pfizer and BioNTech sued Moderna in London in September, seeking to revoke two of Moderna’s patents in relation to its messenger RNA (mRNA) vaccines.
The Washington-based biotech is focusing on upcoming label expansions and its promising pipeline.
Aera Therapeutics emerged from stealth mode Thursday with a platform based on the work of Feng Zhang, Ph.D. and ex-Alnylam executive Akin Akinc at the helm.
Through the job cuts and other cost-saving measures, Grifols aims to save approximately $428 million USD in 2023, relative to comparative full-year 2022 costs, according to the company.
However, Labcorp’s forecast is steeper than that of its closest rival Quest, which sees COVID sales declining by as much as 88% this year.
The vote puts the naloxone-based treatment Narcan on track to potentially become the first opioid overdose drug to be sold OTC nationwide.
The U.S. National Institutes of Health (NIH) said on Wednesday that it had started a clinical trial to evaluate Japan’s Shionogi & Co. Ltd.’s experimental oral antiviral drug to treat COVID-19.
The European Medicines Agency (EMA) expects COVID vaccination campaigns to be conducted once a year, similar to the approach with flu inoculation, it said on Wednesday.